Optoceutics seeks to provide the cutting edge of technology advancements within brain stimulation to patients, enabling better personalized care, and ultimately,
Read more
Pre-order here
Investigational use
Optoceutics is currently planning clinical trials on the potential effect of masked 40 Hz light on Alzheimer’s Disease patients.
The device to be used in the trials is considered an Investigational Device and limited by United States law to investigational use.
Sign up for our newsletter to stay up to date on the latest information
SELECTED PARTNERS
